INR Management: Adjusting Warfarin Dose Based on Blood Test Results
The International Normalized Ratio (INR) standardizes prothrombin time (PT) to monitor warfarin therapy. Target INR depends on indication.
Common Target INR Ranges
- Atrial fibrillation, VTE treatment/prevention: 2.0–3.0
- Mechanical mitral valve, high-risk mechanical aortic valve: 2.5–3.5
- Mechanical aortic valve (bileaflet, no risk factors): 2.0–3.0
- Antiphospholipid syndrome (arterial thrombosis): 3.0–4.0
Dose Adjustment Principles
- INR above target: Bleeding risk ↑ → hold 1–2 doses, reduce weekly dose by 10–20%, recheck in 1–3 days. If INR >5.0 without bleeding: hold warfarin, consider oral vitamin K 1–2.5 mg.
- INR below target: Thrombosis risk ↑ → increase weekly dose by 10–20%, recheck in 1–2 weeks. If subtherapeutic with thrombosis: bridge with heparin/LMWH.
- Small, frequent adjustments are better than large swings.
Factors Affecting INR
- Dietary vitamin K (leafy greens) – consistency is key.
- Drug interactions (antibiotics, amiodarone, antifungals, NSAIDs, herbals).
- Alcohol, acute illness, liver function, thyroid status.
- Adherence.
Monitoring
- Frequent initially (2–3×/week), then weekly, then every 2–4 weeks when stable.
- Point-of-care testing enables self-management programs.
Always adjust warfarin under clinician supervision. Never self-adjust without guidance.
Blood Disorders - Related Articles
- Ibn al-Nafis and the Discovery of Pulmonary Circulation
- Blood Clot Formation (Thrombosis): Cellular and Molecular Steps
- Arm Blood Clot: Symptoms, Causes & What to Do
- Vitamins for Improved Circulation: A Natural Approach
- Blood Type vs. Body Type: Understanding the Difference
- Donate Plasma for Cash in Omaha, NE: Eligibility & Process
- Universal Donor Blood Type O: Why O Negative Can Give to Anyone
